Glimepiride Information
What's inside Glimepiride
Glimepiride Active Ingredients: glimepiride, details.| Glimepiride Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Glimepiride 4 mg | tablet | oral | 1.0 each | OTC |
| Glimepiride 2 mg | tablet | oral | 1.0 each | OTC |
| Glimepiride 1 mg | tablet | oral | 1.0 each | OTC |
Glimepiride in the News
EMEA Recommends New Warnings and Contraindications for Rosiglitazone - Lifescience-online
... in the European Union as Avandia (rosiglitazone maleate), Avandamet (rosiglitazone maleate/metformin) and Avaglim (rosiglitazone maleate/glimepiride). ...
Mon Jan 28 06:36:03 -0500 2008
Novo Nordisk Reports Results From Liraglutide Study - FDA news (subscription)
The study, which is part of Novo Nordisk’s LEAD program, included 746 patients who received one of two doses of liraglutide or 8 mg of glimepiride, ...
Tue Dec 11 17:49:17 -0500 2007
Novo Nordisk says phase 3 Liraglutide trials show very favourable ... - CNNMoney.com
In this final study 746 patients with type 2 diabetes were given either one of two doses of liraglutide or 8 mg (maximum dose) of glimepiride, a widely used ...
Tue Dec 11 10:36:37 -0500 2007
Glimepiride Chemical Information
glimepiride - A sulfonylurea with antihyperglycemic activity. Glimepiride binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, thereby reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-gated calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin, and thereby results in a reduction of the blood glucose level. In addition, this agent increases the sensitivity of peripheral tissues to insulin.
Glimepiride RSS Feed
